Check out the companies making headlines in midday trading: Drugmakers — Pharmaceutical stocks bounced back from earlier losses after an executive order aimed at bringing down drug prices was deemed not as bad as feared for the industry. Merck jumped 5%, while Pfizer , Bristol-Myers Squibb and Eli Lilly all rose more than 2%. However, pharmacy chain CVS Health tumbled 5% as part of the order called for a platform that allowed Americans to buy products directly from manufacturers. Tech stocks — Shares of megacap technology companies saw a broad rally on Monday after the U.S. and China agreed to suspend most tariffs on each other's goods. Shares of Tesla and Amazon , which have both seen declining China sales, each rose about 7%. Apple , which makes the majority of its iPhones in China, gained more than 5%. Meta Platforms jumped 7%. Semiconductor stocks Nvidia , Broadcom and ON Semiconductor also rose. Chegg — Shares popped 2% after the educational technology company said it would lay off 22% of its workforce . The cuts come as the company contends with declining web traffic as students favor artificial intelligence tools when utilizing education tech services. China stocks — U.S.-listed shares of Chinese companies moved higher on the heels of the tariff agreement between the U.S. and China. Shares of e-commerce giants PDD Holdings and Alibaba each rose more than 6%, as did fellow e-commerce name JD.com . Tech giant Baidu also surged 5%. KindlyMD — The health-care company surged about 300% on news that it is merging with Nakamoto , a bitcoin investment company founded by David Bailey, who is a key cryptocurrency advisor to President Donald Trump. Retail stocks — Retailers sensitive to tariffs on Chinese imports jumped after the U.S. and China came to a temporary agreement to slash levies. Five Below and RH both soared about 17%, while Nike , Lululemon and Estée Lauder added about 7%. E.l.f Beauty and Williams-Sonoma gained nearly 8%, and Best Buy moved 5% higher. NRG Energy — Shares of the energy company popped about 23% after the company announced on Monday that it will acquire a power portfolio from LS Power for $12 billion. The deal for the portfolio, which includes several natural gas generation facilities across nine states, is expected to close in the first quarter of next year. Las Vegas Sands , Wynn Resorts — Casino stocks surged on Monday, outpacing the broader markets, after the U.S. and China announced a 90-day pause on most of the tariffs between the two countries. Shares of Las Vegas Sands rose 5.9%, while Wynn Resorts jumped 7.8%. Both companies have significant exposure to the Chinese economy through their properties in Macao. — CNBC's Alex Harring, Sean Conlon, Jesse Pound and Michelle Fox contributed reporting.
Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...